Last updated:
This attempt of neurralink is an important step in brain-computer interface technology, which can open new possibilities to treat serious neurological conditions in the future.
Alan Musk said that in 2025, there are plans to apply chip to the brain of 20 to 30 humans.
New Delhi. Alan Masak's company Nuralink Corp has successfully transmitted its brain-computer device to the third patient's brain. Earlier, the neuralic had successfully put a computer chip in the minds of two people and now the company has succeeded in doing so once again. Alan Masak himself gave this information at an event held in Las Vegas. Masak told that in 2025 there are plans to put a chip in the brain of 20 to 30 humans.
Neuralink is one of the startups that are developing brain implants that can help in treating diseases such as paralysis (paralysis) and ALS. A year ago, Nuralink imposed this device in the brain of Noland Arbuck, its first patient. In September 2023, Musk's brain-chip company Nuralink received recruitment from the Independent Institutional Review Board for its first human trial.
Also read- Meet AI robot girlfriend 'Aria', kills its performances; Hearing the price, people said – the expenditure is less than the real girlfriend
Smartphone will be controlled by mind
Alan Musk said on the third trial of the Nuraralink, “We have so far applied neurolink in the minds of three humans, and they are all working well.” Significantly, the company has registered two studies with Food and Drug Administration (FDA) in the US for its device. The first prime study of these is designed for five patients, which allows patients suffering from paralysis to control external devices such as computers or smartphones from their brain. The second study Convoy is for three patients, in which they can control equipment such as auxiliary robotic arms.
This attempt of neurralink is an important step in brain-computer interface technology, which can open new possibilities to treat serious neurological conditions in the future. If the human trial is successful, then blind people will be able to see through the chip. Paralysis patients will be able to walk and also run computers. The company has named this chip 'Link'.
The trial is being done on those who have a cervical spinal cord injury or amotrophic lateral sclerosis (ALS). The age of those who participate in this trial should be minimum 22 years. The study will take about 6 years to complete. During this time, the company also gives the travel expenses to the participant to the lab.
